Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (0HD2.L) Stock Competitors & Peer Comparison
See (0HD2.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0HD2.L | £446.47 | -4.06% | 58.5B | -59.61 | -£7.49 | N/A |
| 0R0H.L | £491.54 | +0.36% | 185.6B | 25.62 | £19.19 | +0.33% |
| 0QZU.L | £389.24 | -2.06% | 99.8B | 41.08 | £9.48 | N/A |
| 0M3Q.L | £155.43 | -1.17% | 68.9B | 35.66 | £4.36 | +1.25% |
| 0R2M.L | £573.42 | -4.58% | 59.7B | 8.16 | £70.31 | +0.46% |
| 0RD1.L | £713.25 | +5.20% | 41.3B | -549.21 | -£1.27 | N/A |
| 0HAV.L | £119.39 | +1.05% | 33.9B | 28.80 | £4.15 | +0.82% |
| 0JDM.L | £187.94 | +0.13% | 31.9B | 33.94 | £5.54 | N/A |
| 0JAV.L | £130.54 | -0.71% | 27.6B | -34.56 | -£3.78 | N/A |
| 0K10.L | £1,299.96 | +0.09% | 26.8B | 38.18 | £34.05 | N/A |
Stock Comparison
0HD2.L vs 0R0H.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0R0H.L has a market cap of 185.6B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0R0H.L trades at £491.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0R0H.L's P/E ratio is 25.62. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0HD2.L is more volatile compared to 0R0H.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0R0H.L's competition here
0HD2.L vs 0QZU.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QZU.L has a market cap of 99.8B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QZU.L trades at £389.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QZU.L's P/E ratio is 41.08. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QZU.L's ROE of +0.22%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QZU.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QZU.L's competition here
0HD2.L vs 0M3Q.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0M3Q.L has a market cap of 68.9B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0M3Q.L trades at £155.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0M3Q.L's P/E ratio is 35.66. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0M3Q.L's ROE of +0.53%. Regarding short-term risk, 0HD2.L is more volatile compared to 0M3Q.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0M3Q.L's competition here
0HD2.L vs 0R2M.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0R2M.L has a market cap of 59.7B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0R2M.L trades at £573.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0R2M.L's P/E ratio is 8.16. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0R2M.L's ROE of +0.15%. Regarding short-term risk, 0HD2.L is less volatile compared to 0R2M.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0R2M.L's competition here
0HD2.L vs 0RD1.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RD1.L has a market cap of 41.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RD1.L trades at £713.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RD1.L's P/E ratio is -549.21. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RD1.L's ROE of +0.21%. Regarding short-term risk, 0HD2.L is more volatile compared to 0RD1.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0RD1.L's competition here
0HD2.L vs 0HAV.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HAV.L has a market cap of 33.9B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HAV.L trades at £119.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HAV.L's P/E ratio is 28.80. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HAV.L's ROE of +0.19%. Regarding short-term risk, 0HD2.L is more volatile compared to 0HAV.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0HAV.L's competition here
0HD2.L vs 0JDM.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JDM.L has a market cap of 31.9B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JDM.L trades at £187.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JDM.L's P/E ratio is 33.94. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JDM.L's ROE of +0.20%. Regarding short-term risk, 0HD2.L is more volatile compared to 0JDM.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0JDM.L's competition here
0HD2.L vs 0JAV.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JAV.L has a market cap of 27.6B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JAV.L trades at £130.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JAV.L's P/E ratio is -34.56. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JAV.L's ROE of -1.95%. Regarding short-term risk, 0HD2.L is less volatile compared to 0JAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0JAV.L's competition here
0HD2.L vs 0K10.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0K10.L has a market cap of 26.8B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0K10.L trades at £1,299.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0K10.L's P/E ratio is 38.18. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0K10.L's ROE of -4.60%. Regarding short-term risk, 0HD2.L is more volatile compared to 0K10.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0K10.L's competition here
0HD2.L vs 0SAN.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0SAN.L has a market cap of 22.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0SAN.L trades at £50.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0SAN.L's P/E ratio is N/A. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0SAN.L's ROE of +0.00%. Regarding short-term risk, 0HD2.L is more volatile compared to 0SAN.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0SAN.L's competition here
0HD2.L vs 0R1B.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0R1B.L has a market cap of 20.1B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0R1B.L trades at £137.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0R1B.L's P/E ratio is N/A. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0R1B.L's ROE of +0.09%. Regarding short-term risk, 0HD2.L is less volatile compared to 0R1B.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0R1B.L's competition here
0HD2.L vs 0REZ.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0REZ.L has a market cap of 20.1B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0REZ.L trades at £173.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0REZ.L's P/E ratio is 29.14. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0REZ.L's ROE of +0.06%. Regarding short-term risk, 0HD2.L is more volatile compared to 0REZ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0REZ.L's competition here
0HD2.L vs 0RQO.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RQO.L has a market cap of 19.7B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RQO.L trades at £295.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RQO.L's P/E ratio is -234.85. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RQO.L's ROE of +0.20%. Regarding short-term risk, 0HD2.L is more volatile compared to 0RQO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0RQO.L's competition here
0HD2.L vs 0LTI.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0LTI.L has a market cap of 17.8B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0LTI.L trades at £298.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0LTI.L's P/E ratio is 26.14. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0LTI.L's ROE of +0.35%. Regarding short-term risk, 0HD2.L is more volatile compared to 0LTI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0LTI.L's competition here
0HD2.L vs 0J9P.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0J9P.L has a market cap of 16.7B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0J9P.L trades at £85.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0J9P.L's P/E ratio is 20.38. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0J9P.L's ROE of +0.24%. Regarding short-term risk, 0HD2.L is more volatile compared to 0J9P.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0J9P.L's competition here
0HD2.L vs 0J8Z.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0J8Z.L has a market cap of 15.4B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0J8Z.L trades at £99.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0J8Z.L's P/E ratio is 21.93. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0J8Z.L's ROE of +0.53%. Regarding short-term risk, 0HD2.L is more volatile compared to 0J8Z.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0J8Z.L's competition here
0HD2.L vs 0K6R.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0K6R.L has a market cap of 13.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0K6R.L trades at £134.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0K6R.L's P/E ratio is 183.70. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0K6R.L's ROE of +0.13%. Regarding short-term risk, 0HD2.L is more volatile compared to 0K6R.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0K6R.L's competition here
0HD2.L vs 0HNC.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HNC.L has a market cap of 11.1B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HNC.L trades at £57.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HNC.L's P/E ratio is 269.64. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HNC.L's ROE of +0.11%. Regarding short-term risk, 0HD2.L is less volatile compared to 0HNC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0HNC.L's competition here
0HD2.L vs 0LSZ.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0LSZ.L has a market cap of 10.5B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0LSZ.L trades at £11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0LSZ.L's P/E ratio is 1.66. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0LSZ.L's ROE of -0.70%. Regarding short-term risk, 0HD2.L is more volatile compared to 0LSZ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0LSZ.L's competition here
0HD2.L vs 0IJO.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IJO.L has a market cap of 10.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IJO.L trades at £38.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IJO.L's P/E ratio is 41.26. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IJO.L's ROE of +0.28%. Regarding short-term risk, 0HD2.L is more volatile compared to 0IJO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0IJO.L's competition here
0HD2.L vs 0J2O.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0J2O.L has a market cap of 8.4B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0J2O.L trades at £72.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0J2O.L's P/E ratio is 24.06. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0J2O.L's ROE of +1.37%. Regarding short-term risk, 0HD2.L is more volatile compared to 0J2O.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0J2O.L's competition here
0HD2.L vs 0I3Q.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0I3Q.L has a market cap of 7.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0I3Q.L trades at £69.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0I3Q.L's P/E ratio is 76.01. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0I3Q.L's ROE of +0.20%. Regarding short-term risk, 0HD2.L is more volatile compared to 0I3Q.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0I3Q.L's competition here
0HD2.L vs 0JDI.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JDI.L has a market cap of 6.7B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JDI.L trades at £41.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JDI.L's P/E ratio is -1499.29. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JDI.L's ROE of -0.45%. Regarding short-term risk, 0HD2.L is less volatile compared to 0JDI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0JDI.L's competition here
0HD2.L vs 0HOJ.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HOJ.L has a market cap of 6.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HOJ.L trades at £129.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HOJ.L's P/E ratio is -11.70. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HOJ.L's ROE of -0.49%. Regarding short-term risk, 0HD2.L is more volatile compared to 0HOJ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0HOJ.L's competition here
0HD2.L vs 0HKF.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HKF.L has a market cap of 5.7B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HKF.L trades at £116.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HKF.L's P/E ratio is -31.31. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HKF.L's ROE of -3.58%. Regarding short-term risk, 0HD2.L is less volatile compared to 0HKF.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0HKF.L's competition here
0HD2.L vs 0QND.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QND.L has a market cap of 5B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QND.L trades at £64.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QND.L's P/E ratio is 40.98. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QND.L's ROE of +0.09%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QND.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QND.L's competition here
0HD2.L vs 0RA9.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RA9.L has a market cap of 5B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RA9.L trades at £64.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RA9.L's P/E ratio is -26.60. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RA9.L's ROE of -2.11%. Regarding short-term risk, 0HD2.L is more volatile compared to 0RA9.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0RA9.L's competition here
0HD2.L vs 0VGI.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0VGI.L has a market cap of 4.5B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0VGI.L trades at £28.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0VGI.L's P/E ratio is -11.42. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0VGI.L's ROE of +0.29%. Regarding short-term risk, 0HD2.L is more volatile compared to 0VGI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0VGI.L's competition here
0HD2.L vs 0QQO.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QQO.L has a market cap of 3.8B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QQO.L trades at £85.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QQO.L's P/E ratio is 3.92. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QQO.L's ROE of +0.17%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QQO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QQO.L's competition here
0HD2.L vs 0Y5E.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0Y5E.L has a market cap of 3.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0Y5E.L trades at £23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0Y5E.L's P/E ratio is -29.28. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0Y5E.L's ROE of -0.02%. Regarding short-term risk, 0HD2.L is more volatile compared to 0Y5E.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0Y5E.L's competition here
0HD2.L vs 0ILL.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0ILL.L has a market cap of 3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0ILL.L trades at £57.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0ILL.L's P/E ratio is 17.67. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0ILL.L's ROE of +0.23%. Regarding short-term risk, 0HD2.L is more volatile compared to 0ILL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0ILL.L's competition here
0HD2.L vs 0VQA.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0VQA.L has a market cap of 2.9B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0VQA.L trades at £25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0VQA.L's P/E ratio is -34.92. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0VQA.L's ROE of -0.20%. Regarding short-term risk, 0HD2.L is more volatile compared to 0VQA.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0VQA.L's competition here
0HD2.L vs 0LB2.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0LB2.L has a market cap of 2.5B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0LB2.L trades at £45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0LB2.L's P/E ratio is 34.25. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0LB2.L's ROE of +0.06%. Regarding short-term risk, 0HD2.L is more volatile compared to 0LB2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0LB2.L's competition here
0HD2.L vs 0GZB.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0GZB.L has a market cap of 2.3B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0GZB.L trades at £203.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0GZB.L's P/E ratio is 31.04. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0GZB.L's ROE of +0.01%. Regarding short-term risk, 0HD2.L is more volatile compared to 0GZB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0GZB.L's competition here
0HD2.L vs 0QLN.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QLN.L has a market cap of 2.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QLN.L trades at £174.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QLN.L's P/E ratio is 17.80. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QLN.L's ROE of +0.05%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QLN.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QLN.L's competition here
0HD2.L vs 0HB0.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HB0.L has a market cap of 2.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HB0.L trades at £38.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HB0.L's P/E ratio is -5.93. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HB0.L's ROE of +0.43%. Regarding short-term risk, 0HD2.L is less volatile compared to 0HB0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0HB0.L's competition here
0HD2.L vs 0HF9.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HF9.L has a market cap of 2.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HF9.L trades at £7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HF9.L's P/E ratio is -7.69. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HF9.L's ROE of -0.20%. Regarding short-term risk, 0HD2.L is more volatile compared to 0HF9.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0HF9.L's competition here
0HD2.L vs 0I5P.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0I5P.L has a market cap of 2.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0I5P.L trades at £32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0I5P.L's P/E ratio is -24.55. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0I5P.L's ROE of -0.64%. Regarding short-term risk, 0HD2.L is more volatile compared to 0I5P.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0I5P.L's competition here
0HD2.L vs 0L35.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0L35.L has a market cap of 1.8B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0L35.L trades at £18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0L35.L's P/E ratio is -4.35. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0L35.L's ROE of -0.04%. Regarding short-term risk, 0HD2.L is less volatile compared to 0L35.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0L35.L's competition here
0HD2.L vs 0IMT.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IMT.L has a market cap of 1.7B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IMT.L trades at £62.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IMT.L's P/E ratio is -24.62. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IMT.L's ROE of -0.01%. Regarding short-term risk, 0HD2.L is more volatile compared to 0IMT.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0IMT.L's competition here
0HD2.L vs 0IDA.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IDA.L has a market cap of 1.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IDA.L trades at £10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IDA.L's P/E ratio is 13.65. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IDA.L's ROE of -0.09%. Regarding short-term risk, 0HD2.L is less volatile compared to 0IDA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0IDA.L's competition here
0HD2.L vs 0JBU.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JBU.L has a market cap of 1.2B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JBU.L trades at £11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JBU.L's P/E ratio is -2.24. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JBU.L's ROE of -0.58%. Regarding short-term risk, 0HD2.L is more volatile compared to 0JBU.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0JBU.L's competition here
0HD2.L vs 0KCS.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0KCS.L has a market cap of 1.1B. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0KCS.L trades at £1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0KCS.L's P/E ratio is -7.94. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0KCS.L's ROE of -0.13%. Regarding short-term risk, 0HD2.L is less volatile compared to 0KCS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0KCS.L's competition here
0HD2.L vs 0JDK.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JDK.L has a market cap of 935.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JDK.L trades at £2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JDK.L's P/E ratio is -1.12. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JDK.L's ROE of -0.53%. Regarding short-term risk, 0HD2.L is less volatile compared to 0JDK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0JDK.L's competition here
0HD2.L vs 0RGI.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RGI.L has a market cap of 934.8M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RGI.L trades at £58.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RGI.L's P/E ratio is 44.94. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RGI.L's ROE of +0.27%. Regarding short-term risk, 0HD2.L is more volatile compared to 0RGI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0RGI.L's competition here
0HD2.L vs 0IV3.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IV3.L has a market cap of 921.9M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IV3.L trades at £1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IV3.L's P/E ratio is -4.03. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IV3.L's ROE of -0.32%. Regarding short-term risk, 0HD2.L is more volatile compared to 0IV3.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0IV3.L's competition here
0HD2.L vs 0O1O.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0O1O.L has a market cap of 876.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0O1O.L trades at £72.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0O1O.L's P/E ratio is 13.98. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0O1O.L's ROE of +0.10%. Regarding short-term risk, 0HD2.L is more volatile compared to 0O1O.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0O1O.L's competition here
0HD2.L vs 0EE0.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0EE0.L has a market cap of 812.9M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0EE0.L trades at £15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0EE0.L's P/E ratio is 2.28. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0EE0.L's ROE of -10.11%. Regarding short-term risk, 0HD2.L is less volatile compared to 0EE0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0EE0.L's competition here
0HD2.L vs 0HFR.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HFR.L has a market cap of 805.8M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HFR.L trades at £9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HFR.L's P/E ratio is -16.20. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HFR.L's ROE of -0.33%. Regarding short-term risk, 0HD2.L is less volatile compared to 0HFR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0HFR.L's competition here
0HD2.L vs 0OB3.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0OB3.L has a market cap of 663.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0OB3.L trades at £3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0OB3.L's P/E ratio is -5.52. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0OB3.L's ROE of -0.35%. Regarding short-term risk, 0HD2.L is less volatile compared to 0OB3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0OB3.L's competition here
0HD2.L vs 0RNK.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RNK.L has a market cap of 576.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RNK.L trades at £4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RNK.L's P/E ratio is -3.27. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RNK.L's ROE of +1.98%. Regarding short-term risk, 0HD2.L is less volatile compared to 0RNK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0RNK.L's competition here
0HD2.L vs 0QNA.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QNA.L has a market cap of 573.8M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QNA.L trades at £46.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QNA.L's P/E ratio is -79.83. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QNA.L's ROE of +1.59%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QNA.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QNA.L's competition here
0HD2.L vs 0LOV.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0LOV.L has a market cap of 560.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0LOV.L trades at £9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0LOV.L's P/E ratio is -22.16. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0LOV.L's ROE of -95.87%. Regarding short-term risk, 0HD2.L is more volatile compared to 0LOV.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0LOV.L's competition here
0HD2.L vs 0K3W.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0K3W.L has a market cap of 547.8M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0K3W.L trades at £5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0K3W.L's P/E ratio is -54.04. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0K3W.L's ROE of -0.63%. Regarding short-term risk, 0HD2.L is more volatile compared to 0K3W.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0K3W.L's competition here
0HD2.L vs 0UNL.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0UNL.L has a market cap of 505.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0UNL.L trades at £26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0UNL.L's P/E ratio is -9.98. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0UNL.L's ROE of -4.93%. Regarding short-term risk, 0HD2.L is more volatile compared to 0UNL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0UNL.L's competition here
0HD2.L vs 0IGA.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IGA.L has a market cap of 482.9M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IGA.L trades at £9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IGA.L's P/E ratio is 3.05. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IGA.L's ROE of +0.27%. Regarding short-term risk, 0HD2.L is more volatile compared to 0IGA.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0IGA.L's competition here
0HD2.L vs 0W4N.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0W4N.L has a market cap of 435.5M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0W4N.L trades at £24.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0W4N.L's P/E ratio is -20.24. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0W4N.L's ROE of -0.24%. Regarding short-term risk, 0HD2.L is more volatile compared to 0W4N.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0W4N.L's competition here
0HD2.L vs 0IIM.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IIM.L has a market cap of 424.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IIM.L trades at £2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IIM.L's P/E ratio is -0.35. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IIM.L's ROE of +0.32%. Regarding short-term risk, 0HD2.L is less volatile compared to 0IIM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0IIM.L's competition here
0HD2.L vs 0K16.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0K16.L has a market cap of 397.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0K16.L trades at £14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0K16.L's P/E ratio is -11.22. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0K16.L's ROE of +17.91%. Regarding short-term risk, 0HD2.L is more volatile compared to 0K16.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0K16.L's competition here
0HD2.L vs 0DTF.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0DTF.L has a market cap of 382M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0DTF.L trades at £21.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0DTF.L's P/E ratio is 13.50. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0DTF.L's ROE of +0.03%. Regarding short-term risk, 0HD2.L is more volatile compared to 0DTF.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0DTF.L's competition here
0HD2.L vs 0QAV.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QAV.L has a market cap of 377M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QAV.L trades at £7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QAV.L's P/E ratio is -5.88. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QAV.L's ROE of +1.56%. Regarding short-term risk, 0HD2.L is less volatile compared to 0QAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0QAV.L's competition here
0HD2.L vs 0H7R.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0H7R.L has a market cap of 342.3M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0H7R.L trades at £7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0H7R.L's P/E ratio is -8.84. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0H7R.L's ROE of +0.78%. Regarding short-term risk, 0HD2.L is more volatile compared to 0H7R.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0H7R.L's competition here
0HD2.L vs 0IFK.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IFK.L has a market cap of 249M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IFK.L trades at £2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IFK.L's P/E ratio is -1.01. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IFK.L's ROE of -2.42%. Regarding short-term risk, 0HD2.L is less volatile compared to 0IFK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0IFK.L's competition here
0HD2.L vs 0GP7.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0GP7.L has a market cap of 229.9M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0GP7.L trades at £2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0GP7.L's P/E ratio is -1.29. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0GP7.L's ROE of -0.38%. Regarding short-term risk, 0HD2.L is less volatile compared to 0GP7.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0GP7.L's competition here
0HD2.L vs 0RDB.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RDB.L has a market cap of 225.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RDB.L trades at £2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RDB.L's P/E ratio is -33.01. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RDB.L's ROE of -0.05%. Regarding short-term risk, 0HD2.L is more volatile compared to 0RDB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0RDB.L's competition here
0HD2.L vs 0J4V.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0J4V.L has a market cap of 214.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0J4V.L trades at £1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0J4V.L's P/E ratio is -0.61. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0J4V.L's ROE of +0.03%. Regarding short-term risk, 0HD2.L is more volatile compared to 0J4V.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0J4V.L's competition here
0HD2.L vs 0NZY.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0NZY.L has a market cap of 201.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0NZY.L trades at £39.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0NZY.L's P/E ratio is 30.50. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0NZY.L's ROE of +0.16%. Regarding short-term risk, 0HD2.L is more volatile compared to 0NZY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0NZY.L's competition here
0HD2.L vs 0H8T.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0H8T.L has a market cap of 185.9M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0H8T.L trades at £1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0H8T.L's P/E ratio is -1.33. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0H8T.L's ROE of -0.96%. Regarding short-term risk, 0HD2.L is more volatile compared to 0H8T.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0H8T.L's competition here
0HD2.L vs 0QN1.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QN1.L has a market cap of 184.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QN1.L trades at £13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QN1.L's P/E ratio is -8.76. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QN1.L's ROE of -1.11%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QN1.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QN1.L's competition here
0HD2.L vs 0QOI.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QOI.L has a market cap of 173.5M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QOI.L trades at £8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QOI.L's P/E ratio is -10.22. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QOI.L's ROE of -1.08%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QOI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QOI.L's competition here
0HD2.L vs 0R1D.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0R1D.L has a market cap of 169.1M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0R1D.L trades at £0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0R1D.L's P/E ratio is -0.46. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0R1D.L's ROE of -2.93%. Regarding short-term risk, 0HD2.L is less volatile compared to 0R1D.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0R1D.L's competition here
0HD2.L vs 0OCQ.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0OCQ.L has a market cap of 135.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0OCQ.L trades at £0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0OCQ.L's P/E ratio is -4.79. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0OCQ.L's ROE of -4.66%. Regarding short-term risk, 0HD2.L is less volatile compared to 0OCQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0OCQ.L's competition here
0HD2.L vs 0SZI.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0SZI.L has a market cap of 128.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0SZI.L trades at £10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0SZI.L's P/E ratio is -33.59. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0SZI.L's ROE of -0.44%. Regarding short-term risk, 0HD2.L is less volatile compared to 0SZI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0SZI.L's competition here
0HD2.L vs 0N4A.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0N4A.L has a market cap of 126.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0N4A.L trades at £0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0N4A.L's P/E ratio is -0.90. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0N4A.L's ROE of -0.23%. Regarding short-term risk, 0HD2.L is more volatile compared to 0N4A.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0N4A.L's competition here
0HD2.L vs 0O8G.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0O8G.L has a market cap of 115.1M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0O8G.L trades at £3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0O8G.L's P/E ratio is -14.05. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0O8G.L's ROE of -5.35%. Regarding short-term risk, 0HD2.L is more volatile compared to 0O8G.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0O8G.L's competition here
0HD2.L vs 0QXX.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QXX.L has a market cap of 107.1M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QXX.L trades at £2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QXX.L's P/E ratio is 0.88. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QXX.L's ROE of -0.42%. Regarding short-term risk, 0HD2.L is more volatile compared to 0QXX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0QXX.L's competition here
0HD2.L vs 0HIY.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HIY.L has a market cap of 86.1M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HIY.L trades at £12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HIY.L's P/E ratio is -3.36. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HIY.L's ROE of -0.08%. Regarding short-term risk, 0HD2.L is more volatile compared to 0HIY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0HIY.L's competition here
0HD2.L vs 0Q77.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0Q77.L has a market cap of 81M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0Q77.L trades at £1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0Q77.L's P/E ratio is -4.18. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0Q77.L's ROE of +0.32%. Regarding short-term risk, 0HD2.L is more volatile compared to 0Q77.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0Q77.L's competition here
0HD2.L vs 0KCC.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0KCC.L has a market cap of 69.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0KCC.L trades at £2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0KCC.L's P/E ratio is -3.15. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0KCC.L's ROE of -28.98%. Regarding short-term risk, 0HD2.L is more volatile compared to 0KCC.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0KCC.L's competition here
0HD2.L vs 0JQ2.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JQ2.L has a market cap of 64.3M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JQ2.L trades at £9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JQ2.L's P/E ratio is N/A. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JQ2.L's ROE of -6.86%. Regarding short-term risk, 0HD2.L is more volatile compared to 0JQ2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0JQ2.L's competition here
0HD2.L vs 0HX7.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HX7.L has a market cap of 59.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HX7.L trades at £0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HX7.L's P/E ratio is -0.68. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HX7.L's ROE of -0.68%. Regarding short-term risk, 0HD2.L is less volatile compared to 0HX7.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0HX7.L's competition here
0HD2.L vs 0DOL.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0DOL.L has a market cap of 52.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0DOL.L trades at £1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0DOL.L's P/E ratio is 4.37. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0DOL.L's ROE of -0.25%. Regarding short-term risk, 0HD2.L is more volatile compared to 0DOL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0DOL.L's competition here
0HD2.L vs 0M40.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0M40.L has a market cap of 49M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0M40.L trades at £1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0M40.L's P/E ratio is -1.36. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0M40.L's ROE of -0.59%. Regarding short-term risk, Volatility data is not available for a full comparison. 0HD2.L has daily volatility of 2.77 and 0M40.L has daily volatility of N/A.Check 0M40.L's competition here
0HD2.L vs 0HOH.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0HOH.L has a market cap of 48.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0HOH.L trades at £8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0HOH.L's P/E ratio is -0.77. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0HOH.L's ROE of +18.95%. Regarding short-term risk, 0HD2.L is more volatile compared to 0HOH.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0HOH.L's competition here
0HD2.L vs 0RU5.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0RU5.L has a market cap of 47.3M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0RU5.L trades at £1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0RU5.L's P/E ratio is -0.35. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0RU5.L's ROE of -1.02%. Regarding short-term risk, 0HD2.L is more volatile compared to 0RU5.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0RU5.L's competition here
0HD2.L vs 0IL8.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0IL8.L has a market cap of 43.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0IL8.L trades at £10.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0IL8.L's P/E ratio is -3.57. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0IL8.L's ROE of +0.01%. Regarding short-term risk, 0HD2.L is less volatile compared to 0IL8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0IL8.L's competition here
0HD2.L vs 0R3M.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0R3M.L has a market cap of 37.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0R3M.L trades at £1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0R3M.L's P/E ratio is -2.28. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0R3M.L's ROE of -1.88%. Regarding short-term risk, 0HD2.L is more volatile compared to 0R3M.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0R3M.L's competition here
0HD2.L vs 0JW9.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JW9.L has a market cap of 34.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JW9.L trades at £5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JW9.L's P/E ratio is -9.88. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JW9.L's ROE of -1.27%. Regarding short-term risk, 0HD2.L is less volatile compared to 0JW9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0JW9.L's competition here
0HD2.L vs 0QKQ.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QKQ.L has a market cap of 27.7M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QKQ.L trades at £2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QKQ.L's P/E ratio is -267.00. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QKQ.L's ROE of -0.40%. Regarding short-term risk, 0HD2.L is less volatile compared to 0QKQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0QKQ.L's competition here
0HD2.L vs 0T6G.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0T6G.L has a market cap of 24.6M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0T6G.L trades at £2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0T6G.L's P/E ratio is -42.00. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0T6G.L's ROE of -1.80%. Regarding short-term risk, 0HD2.L is less volatile compared to 0T6G.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0T6G.L's competition here
0HD2.L vs 0JGL.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JGL.L has a market cap of 16.8M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JGL.L trades at £0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JGL.L's P/E ratio is -0.19. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JGL.L's ROE of -0.59%. Regarding short-term risk, 0HD2.L is less volatile compared to 0JGL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0JGL.L's competition here
0HD2.L vs 0QFK.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0QFK.L has a market cap of 11M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0QFK.L trades at £0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0QFK.L's P/E ratio is -0.28. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0QFK.L's ROE of +0.91%. Regarding short-term risk, 0HD2.L is less volatile compared to 0QFK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0QFK.L's competition here
0HD2.L vs 0L85.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0L85.L has a market cap of 7.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0L85.L trades at £0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0L85.L's P/E ratio is N/A. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0L85.L's ROE of -19.05%. Regarding short-term risk, 0HD2.L is less volatile compared to 0L85.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check 0L85.L's competition here
0HD2.L vs 0KF3.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0KF3.L has a market cap of 6.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0KF3.L trades at £6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0KF3.L's P/E ratio is -43.82. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0KF3.L's ROE of +4.54%. Regarding short-term risk, 0HD2.L is more volatile compared to 0KF3.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0KF3.L's competition here
0HD2.L vs CBX.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, CBX.L has a market cap of 2.2M. Regarding current trading prices, 0HD2.L is priced at £446.47, while CBX.L trades at £0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas CBX.L's P/E ratio is -0.37. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to CBX.L's ROE of -0.93%. Regarding short-term risk, 0HD2.L is less volatile compared to CBX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0HD2.L.Check CBX.L's competition here
0HD2.L vs KNB.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, KNB.L has a market cap of 1.4M. Regarding current trading prices, 0HD2.L is priced at £446.47, while KNB.L trades at £0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas KNB.L's P/E ratio is -0.23. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to KNB.L's ROE of -0.80%. Regarding short-term risk, 0HD2.L is more volatile compared to KNB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check KNB.L's competition here
0HD2.L vs 0G99.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0G99.L has a market cap of 1.3M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0G99.L trades at £0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0G99.L's P/E ratio is -0.36. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0G99.L's ROE of -0.01%. Regarding short-term risk, 0HD2.L is more volatile compared to 0G99.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0G99.L's competition here
0HD2.L vs 0YC0.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0YC0.L has a market cap of 1.3M. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0YC0.L trades at £0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0YC0.L's P/E ratio is -0.07. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0YC0.L's ROE of -2.74%. Regarding short-term risk, 0HD2.L is more volatile compared to 0YC0.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0YC0.L's competition here
0HD2.L vs 0JDB.L Comparison August 2025
0HD2.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0HD2.L stands at 58.5B. In comparison, 0JDB.L has a market cap of 114.6K. Regarding current trading prices, 0HD2.L is priced at £446.47, while 0JDB.L trades at £0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0HD2.L currently has a P/E ratio of -59.61, whereas 0JDB.L's P/E ratio is -0.00. In terms of profitability, 0HD2.L's ROE is -2.74%, compared to 0JDB.L's ROE of -2.02%. Regarding short-term risk, 0HD2.L is more volatile compared to 0JDB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0HD2.L.Check 0JDB.L's competition here